Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

SUSS MicroTec Aktie 13673056 / DE000A1K0235

30.10.2025 12:00:03

EQS-News: New SUSS production site in Zhubei has officially opened

EQS-News: SUSS MicroTec SE / Key word(s): Miscellaneous
New SUSS production site in Zhubei has officially opened

30.10.2025 / 12:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


  • Largest international investment project in the company's history completed on schedule
  • Site to support strategic, medium-term growth targets with additional production capacity
  • First tools from new production facility to be delivered to customers in early 2026

Zhubei, Taiwan / Garching, Germany, October 30, 2025 – SUSS, a leading supplier of equipment and process solutions for the semiconductor industry, today celebrated the opening of its new production site in Zhubei, Taiwan, marking an important strategic milestone. “We have built more tools than ever before in the past two years and operated our global production network at full capacity. In Zhubei, we are creating additional capacity to support our medium-term strategic growth plan,” said Dr. Thomas Rohe, Chief Operating Officer (COO) of SUSS. The company now has similarly high and flexible production capacities in Germany and Taiwan, which can be used for different solutions depending on customer demand.

The new location has the potential to double the cleanroom production capacity in Taiwan to 6,300 square meters. The new site has a total indoor area of around 18,000 square meters and offers more than 400 SUSS employees in Taiwan a state-of-the-art building for production, development, service, training, and administration. Due to the high growth in recent years, the workforce in Taiwan was most recently spread across a total of eight locations, which will be vacated once the relocation is complete. The company has invested around € 15 million in the new Zhubei site in recent months – primarily for office and clean room installations. This makes Zhubei the largest international infrastructure project in the history of SUSS to date.

Grand opening with more than 100 guests from the semiconductor community
During the grand opening, which was attended by more than 100 customers, suppliers, political representatives, local authorities, and SUSS employees, Dr. Thomas Rohe highlighted the significance of Taiwan for the company: “A few years ago, we made a conscious decision to establish SUSS’s only production site outside Germany in Taiwan. Since then, we have built a strong reputation as an employer and become an integral part of the Taiwanese semiconductor community.” He also expressed his gratitude to the employees for their dedication: “Everyone involved in the project has worked tirelessly to meet the ambitious schedule, making it possible for us to celebrate this opening today – just one year after signing the long-term lease agreement.”

Expansion of production capacities for future tool generations close to customers
In his speech, Burkhardt Frick, CEO of SUSS, emphasized Taiwan's importance for the semiconductor and semiconductor equipment industry: "Taiwan offers a unique ecosystem with highly skilled workers and suppliers, as well as leading chip manufacturers who produce the majority of the most advanced semiconductors for the global market. We are proud to be part of this ecosystem and to work with our customers to develop pioneering solutions for the industry." As an example, Frick cited the heterogeneous integration of chip modules, which shifts a larger portion of the innovation potential to the backend of the semiconductor value chain. SUSS is addressing this trend with its Advanced Backend Solutions business unit, which contributes two-thirds of the Group's sales with coating, imaging, and bonding solutions. In Taiwan, SUSS currently produces temporary bonders, coaters, and UV projection scanners – all solutions from the Advanced Backend Solutions segment. The first tools to be built in Zhubei are scheduled for delivery in early 2026.

 

Media contact:
Sven Koepsel
Vice President Investor Relations and Communications
E-Mail: sven.koepsel@suss.com
Tel.: +49 89 32007151
About SUSS
SUSS is a leading supplier of equipment and process solutions for microstructuring in the semiconductor industry and related markets. In close cooperation with research institutes and industry partners SUSS contributes to the advancement of next-generation technologies such as 3D Integration and nanoimprint lithography as well as key processes for MEMS and LED manufacturing. With a global infrastructure for applications and service SUSS supports more than 8,000 installed systems worldwide. SUSS is headquartered in Garching near Munich, Germany. The shares of SUSS MicroTec SE are traded in the Prime Standard of the German Stock Exchange (ISIN DE000A10K0235). For more information, please visit suss.com.

 

Legal Disclaimer
All statements in this release other than historical facts are forward-looking statements within the meaning of U.S. Private Securities Litigation Reform Act of 1995. Words such as "believe", "expect", "intend", "anticipate", "estimate", "should", "may", "will", "plan" and similar words and terms used in relation to the enterprise are meant to indicate forward-looking statements of this kind. The company accepts no obligation toward the general public to update or correct forward-looking statements. All forward-looking statements are subject to various risks and uncertainties, as a result of which actual events may diverge numerically from expectations. The forward-looking statements reflect the view at the time they were made.



30.10.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: SUSS MicroTec SE
Schleissheimer Strasse 90
85748 Garching
Germany
Phone: +49 (0)89 32007-151
Fax: +49 (0)89 4444 33420
E-mail: sven.koepsel@suss.com
Internet: www.suss.com
ISIN: DE000A1K0235
WKN: A1K023
Indices: SDAX, TecDax
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2221242

 
End of News EQS News Service

2221242  30.10.2025 CET/CEST

Analysen zu SUSS MicroTec SE (ex SÜSS MicroTec)

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
13:07 SUSS MicroTec Hold Deutsche Bank AG
06:55 SUSS MicroTec Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
29.10.25 SUSS MicroTec Buy Warburg Research
28.10.25 SUSS MicroTec Verkaufen DZ BANK
28.10.25 SUSS MicroTec Buy Warburg Research
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Etienne Jornod (OM Pharma): Führung, Erfolg & Pharma-Strategie- zu Gast im BX Morningcall

Im BX Morning Call spricht die Schweizer Unternehmer-Ikone Etienne Jornod (OM Pharma) mit François Bloch und Olivia Hähnel (BX Swiss) über Führung, Wachstum, Kooperationen, seine Zeit bei der NZZ und darüber, warum Zuhören der wichtigste Leadership-Skill ist.

Die perfekte Folge für alle, die sich für Pharmastrategien, Galenica/Vifor und Unternehmertum interessieren.

🎯 Themen im Interview mit Etienne Jornod (OM Pharma)

– Antrieb und Führungsphilosophie eines Unternehmers
– Erfolgsweg von Galenica – Lehren aus Jahrzehnten Führung
– Frauenquote, Teamkultur und Leadership bei OM Pharma
– Internationale Expansion: China, USA und neue Märkte
– Forschung, Druck und Verantwortung in der Pharmaindustrie
– Inspiration, Balance und persönliche Haltung zum Erfolg
– Zukunftsvisionen: Schweiz, Unternehmertum und Investments

👉🏽 https://bxplus.ch/bx-musterportfolio/

Etienne Jornod (OM Pharma): Führung, Erfolg & Pharma-Strategie- zu Gast im BX Morningcall

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 12’787.24 19.72 BWDSCU
Short 13’059.96 13.87 B7ZS2U
Short 13’578.71 8.76 UJOBSU
SMI-Kurs: 12’305.31 30.10.2025 17:02:31
Long 11’737.17 19.41 SHFB5U
Long 11’450.10 13.42 BK5S8U
Long 10’950.93 8.79 BPOSGU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com